MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$2,895,052
Unit: Dollar
Positive Cash Flow Breakdown
Net proceeds from issuances of c...
Other current liabilities
Research and development supplie...
Others
Negative Cash Flow Breakdown
Net loss
Accounts payable
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-4,447,219
-4,461,895
-3,790,211
-3,799,239
Depreciation
-
-
0
0
Share-based compensation
68,354
73,432
-346,417
385,106
Share-based compensation-The2025Eloc Facility
-
-
284,386
89,996
Prepaid expenses and other
-65,172
227,877
-85,858
-97,553
Research and development supplies
-209,126
-299,020
-45,184
76,072
Accounts payable
-1,361,448
911,959
-876,376
688,634
Other current liabilities
327,316
266,904
499,305
-573,256
Net cash used in operating activities
-5,138,699
-3,138,457
-4,098,271
-3,187,278
Disposals of property and equipment
-
-
0
0
Reductions to intellectual property
-
-
0
0
Net cash provided by investing activities
-
-
0
0
Net proceeds from issuances of common stock
2,243,647
13,356,857
10,825,811
2,943,749
Net cash provided by financing activities
2,243,647
13,356,857
10,825,811
2,943,749
Net increase (decrease) in cash and cash equivalents
-2,895,052
10,218,400
6,727,540
-243,529
Cash and cash equivalents, beginning of period
18,049,255
7,830,855
1,103,315
1,601,660
Cash and cash equivalents, end of period
15,154,203
18,049,255
7,830,855
1,103,315
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net proceeds from
issuances of common stock
$2,243,647
(-71.13%↓ Y/Y)
Net cash provided by
financing activities
$2,243,647
(-71.13%↓ Y/Y)
Net increase
(decrease) in cash and cash...
-$2,895,052
(-1036.13%↓ Y/Y)
Canceled cashflow
$2,243,647
Other current
liabilities
$327,316
(332.72%↑ Y/Y)
Research and development
supplies
-$209,126
(24.10%↑ Y/Y)
Share-based compensation
$68,354
(-75.07%↓ Y/Y)
Prepaid expenses and
other
-$65,172
(-127.91%↓ Y/Y)
Net cash used in
operating activities
-$5,138,699
(35.97%↑ Y/Y)
Canceled cashflow
$669,968
Net loss
-$4,447,219
(48.52%↑ Y/Y)
Accounts payable
-$1,361,448
(-848.85%↓ Y/Y)
Buy us a coffee
Genprex, Inc. (GNPX)
Genprex, Inc. (GNPX)